Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News VRON-0200’s Spark and Fan model: Is Virion Therapeutics unlocking durable immunity against chronic hepatitis B? Virion Therapeutics reports sustained immune responses up to one year after a single VRON-0200 dose for chronic HBV. Find out what makes this a potential game-changer. bySrinathNovember 10, 2025